Citation

BibTex format

@article{Singanayagam:2016:10.5588/ijtld.16.0159,
author = {Singanayagam, A and Manalan, K and Connell, DW and Chalmers, JD and Sridhar, S and Ritchie, AI and Lalvani, A and Wickremasinghe, M and Kon, OM},
doi = {10.5588/ijtld.16.0159},
journal = {International Journal of Tuberculosis and Lung Disease},
pages = {1653--1660},
title = {Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis},
url = {http://dx.doi.org/10.5588/ijtld.16.0159},
volume = {20},
year = {2016}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - OBJECTIVE: To evaluate C-reactive protein (CRP), globulin and white blood cell (WBC) count as predictors of treatment outcome in pulmonary tuberculosis (PTB).METHODS: An observational study of patients with active PTB was conducted at a tertiary centre. All patients had serum CRP, globulin and WBC measured at baseline and at 2 months following commencement of treatment. The outcome of interest was requirement for extension of treatment beyond 6 months.RESULTS: There were 226 patients included in the study. Serum globulin >45 g/l was the only baseline biomarker evaluated that independently predicted requirement for treatment extension (OR 3.42, 95%CI 1.59–7.32, P < 0.001). An elevated globulin level that failed to normalise at 2 months was also associated with increased requirement for treatment extension (63.9% vs. 5.1%, P < 0.001), and had a low negative likelihood ratio (0.07) for exclusion of requirement for treatment extension. On multivariable analysis, an elevated globulin that failed to normalise at 2 months was independently associated with requirement for treatment extension (OR 6.13, 95%CI 2.23–16.80, P < 0.001).CONCLUSIONS: Serum globulin independently predicts requirement for treatment extension in PTB and outperforms CRP and WBC as a predictive biomarker. Normalisation of globulin at 2 months following treatment commencement is associated with low risk of requirement for treatment extension.
AU  - Singanayagam,A
AU  - Manalan,K
AU  - Connell,DW
AU  - Chalmers,JD
AU  - Sridhar,S
AU  - Ritchie,AI
AU  - Lalvani,A
AU  - Wickremasinghe,M
AU  - Kon,OM
DO  - 10.5588/ijtld.16.0159
EP  - 1660
PY  - 2016///
SN  - 1815-7920
SP  - 1653
TI  - Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
T2  - International Journal of Tuberculosis and Lung Disease
UR  - http://dx.doi.org/10.5588/ijtld.16.0159
VL  - 20
ER  -
Download
Faculty of MedicineNational Heart and Lung Institute
NIHR HPRU Important links

Important links

General enquiries

NIHR HPRU in Respiratory Infections

Dr Victor Phillip Dahdaleh (VPD) Building
Level 5, Office 586
Imperial College London
Hammersmith Campus
Du Cane Road
London, W12 0NN

s.evetts@imperial.ac.uk